Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets and Romiplostim Subcutaneous
Determining the interaction of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets and Romiplostim Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets, and Dasabuvir
Generic Name: romiplostim
Brand name: Nplate
Synonyms: Romiplostim, RomiPLOStim
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Romosozumab
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Romosozumab-aqqg
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Ropinirole
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Ropinirole Extended-Release Tablets
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Ropinirole Hydrochloride
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Ropinirole Tablets
- Romiplostim Subcutaneous-Omeclamox-Pak
- Romiplostim Subcutaneous-Omega-3 Fatty Acid Capsules
- Romiplostim Subcutaneous-Omega-3 Fatty Acids
- Romiplostim Subcutaneous-Omega-3 polyunsaturated fatty acids
- Romiplostim Subcutaneous-Omega-3-acid ethyl esters
- Romiplostim Subcutaneous-Omega-3-carboxylic acids